Ellie obtained her BA in Natural Sciences (Pathology) from the University of Cambridge in 2022. She is currently working on her PhD in Stem Cell Biology with the Zilbauer group. Ellie is interested in understanding the mechanisms underlying the chronic and relapsing inflammation associated with IBD, focusing on the role of epithelial MHC-II. Ellie aspires to improve the diagnosis of patients and identify potential therapeutic targets.